Installation
About
Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) doi:10.1093/cid/ciab630.
Key Metrics
Downloads
Yesterday | 10 0% |
Last 7 days | 66 -11% |
Last 30 days | 244 -6% |
Last 90 days | 731 -28% |
Last 365 days | 2.878 +8% |